business insider retatrutide Retatrutide isn't supposed to be everywhere., Touted as the next generation in I'm Worried! Triple Agonist GLP-1

Full dose is typically reached by week 1620

These compounds are not approved by the FDA for use in humans or animals

placebo 22%), although this did not reach statistical significance

Like GLP-1, the GIP receptor likely responds to sustained exposure rather than requiring specific peak concentrations

Progressive overload (gradually increasing weight or reps) maintains the adaptive signal

There is no reason to combine these medications as they target the same receptor so you would just be engaging in overkill with no additional benefits However, there are times when you can add additional or stack peptides such as CJC 1295/Ipamorelin, AOD 9604, or MOTS-C, although these would need pre-approval from one of our medical providers How do I avoid GI (gastrointestinal) upset